Quarterly report · Q1
2150.TEDINET S100TFC8
Period2024-01-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.7bn | 2024-01-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥10.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥545m | 2024-01-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥715m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥564m | 2024-01-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥716m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥516m | 2024-01-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥716m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥311m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥458m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥330m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥464m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥13.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥12.4bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.7bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.5bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.2bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.9bn | at 2023-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥6.98 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.9 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.27 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 81.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 25
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-03-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-03-31 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥423m |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥2.4bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥2.4bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥946m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥266m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥265m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥500,000 |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥23m |
| —segment total | revenue | 2024-01-01 → 2024-03-31 | ¥2.7bn |
| —segment total | revenue external | 2024-01-01 → 2024-03-31 | ¥2.7bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥2m |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | ¥968m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥336m |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥2.3bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥2.3bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥985m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥227m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥227m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥66m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥2.5bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥2.5bn |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 334
| Item | Context | Value | Unit |
|---|---|---|---|
| Foreign exchange gains noi | CurrentYTDDuration | 8442000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 1202000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 713000 | JPY |
| Non operating income | Prior1YTDDuration | 1984000 | JPY |
| Non operating income | CurrentYTDDuration | 21423000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 261000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 161000 | JPY |
| Stock issuance cost noe | Prior1YTDDuration | 0 | JPY |
| Stock issuance cost noe | CurrentYTDDuration | - | JPY |
| Loss on investments in partnership noe | Prior1YTDDuration | 95000 | JPY |
| Loss on investments in partnership noe | CurrentYTDDuration | 83000 | JPY |
| Consumption tax difference noe | Prior1YTDDuration | - | JPY |
| Consumption tax difference noe | CurrentYTDDuration | 2211000 | JPY |
| Miscellaneous loss noe | Prior1YTDDuration | 994000 | JPY |
| Miscellaneous loss noe | CurrentYTDDuration | 591000 | JPY |
| Non operating expenses | Prior1YTDDuration | 1352000 | JPY |
| Non operating expenses | CurrentYTDDuration | 3047000 | JPY |
| Ordinary income | Prior1YTDDuration | 715693000 | JPY |
| Ordinary income | CurrentYTDDuration | 563627000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | - | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | 48018000 | JPY |
| Extraordinary loss | Prior1YTDDuration | - | JPY |
| Extraordinary loss | CurrentYTDDuration | 48018000 | JPY |
| Income before income taxes | Prior1YTDDuration | 715693000 | JPY |
| Income before income taxes | CurrentYTDDuration | 515608000 | JPY |
| Income taxes current | Prior1YTDDuration | 221113000 | JPY |
| Income taxes current | CurrentYTDDuration | 148458000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 30497000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 36731000 | JPY |
| Income taxes | Prior1YTDDuration | 251610000 | JPY |
| Income taxes | CurrentYTDDuration | 185190000 | JPY |
| Profit loss | Prior1YTDDuration | 464082000 | JPY |
| Profit loss | CurrentYTDDuration | 330418000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 6389000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 19583000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 457693000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 310835000 | JPY |
| Profit loss | Prior1YTDDuration | 464082000 | JPY |
| Profit loss | CurrentYTDDuration | 330418000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -11188000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 24516000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -11188000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 24516000 | JPY |
| Comprehensive income | Prior1YTDDuration | 452894000 | JPY |
| Comprehensive income | CurrentYTDDuration | 354935000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 446504000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 335351000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 6389000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 19583000 | JPY |
| Finished goods | Prior1YearInstant | 6879000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |